Converter Impossible Cloud Network ICNT para BioHash BIOHASH

Impossible Cloud Network (ICN) is a decentralized infrastructure protocol that provides enterprise-grade cloud services including storage, compute, and networking. Built as a multi-service DePIN platform, ICN enables hardware providers to contribute resources and service providers to access them using the native token ICNT. The network supports real-world enterprise use cases and is designed to offer high performance, security, and censorship resistance. ICNT is used for collateral by node operators, access to resources by service providers, and staking by the community to secure and participate in the protocol.

BioHash is a decentralized science (DeSci) protocol that builds a transparent on-chain infrastructure for tracking, validating, and pricing biotech and peptide-related data using blockchain technology and AI-assisted systems. At its core, BioHash functions as a real-time oracle layer that converts fragmented off-chain biological and pharmaceutical data (such as vendor pricing, peptide availability, and observational research inputs) into structured, verifiable on-chain commitments. These updates are aggregated through TWAP (time-weighted average price) cycles and anchored to Solana, creating a cryptographically auditable record of live market and research conditions. Each update cycle produces a Merkle-rooted proof of the dataset, which is stored on-chain for integrity, while full provenance data (including sources, timestamps, and statistical adjustments) is made available via decentralized storage. This ensures full transparency, reproducibility, and resistance to manipulation. BioHash is designed to support autonomous scientific and health-focused agents that continuously evaluate new data, run validation checks, and surface emerging signals across the DeSci ecosystem. Over time, this enables a permissionless, data-driven marketplace for bioinformatics, peptide research, and real-world biochemical pricing intelligence. The BioHash ecosystem is currently expanding through indexed peptides, vendor onboarding, and staged validation phases before full inclusion into the oracle network.